The nationally recognized Peckham Center for Cancer and Blood Disorders at Rady Children’s brings together state-of-the-art treatment, personalized care and wraparound support to offer healing and hope to young patients braving childhood cancer and their families.
“Cutting-edge clinical trials are needed to drive advancements in treatment for infant brain and spinal tumors and other childhood cancers that often leave families with limited options and little hope. Thanks to philanthropic support—and wonderful and growing collaborations in San Diego and beyond—I’m optimistic that we can dramatically improve outcomes for pediatric oncology patients.”
Praveen Raju, MD, PhD Nathan Gordon Chair in Neuro-Oncology and director of the Pediatric Neuro-Oncology Program at Rady Children’s
Ranked among the best children’s hospitals in cancer by U.S. News & World Report,
The Peckham Center is at the forefront of advancements in research and care that are accelerating lifesaving progress and helping end the threat of pediatric cancer and blood disorders for every child.
Serving thousands each year through more than 15,000 outpatient visits, 7,000 inpatient visits, and care for 300 newly diagnosed cancer and blood disorder patients, the Peckham Center team addresses the needs of the whole child and family in a space designed for healing, applying transformational discoveries made by its preeminent experts to improve outcomes. Home to renowned pediatric oncology and hematology specialists, the center’s physician-scientists partner with San Diego’s unparalleled medical, pharmaceutical and biotech communities to propel research into promising translational therapies and potential cures.
Rady Children’s is making profound strides to evaluate promising treatments and develop new methodologies to help kids facing cancer recover and thrive.
The Peckham Center is at the forefront of powerful research on brain tumors and leukemia therapies driving better outcomes and brighter futures for children diagnosed with these forms of cancer. Dr. Praveen Raju and his team have advanced nanomedicine approaches that deliver anti-cancer drugs directly to brain tumors and minimize known toxic side effects. They are also advancing precision diagnosis and personalized treatment for every child and tumor type by leveraging increasing knowledge of genomics and immunotherapy and applying machine learning and AI. Simultaneously, a lab led by Preethi Ganesan, MD, PhD, hematologist/oncologist at Rady Children’s is testing immunotherapeutic strategies that engineer patients’ own T cells to target tumors with potential to improve outcomes for children with acute lymphoblastic leukemia (ALL).
Ken Whalen would be proud to celebrate the “warrior spirit” of kids persevering through adverse moments in their lives and overcoming health challenges by supporting the groundbreaking, lifesaving work of the Peckham Center through this legacy event.
Learn more about Rady Children’s Peckham Center for Cancer and Blood Disorders.